MentionFoxPictura Bio US, Inc. filed a Form D with the Securities and Exchange Commission on 2026-09-28.
Pictura Bio US, Inc. filed a Form D notice of an exempt securities offering with the SEC on September 28, 2026. The filing reports $9.13M sold. Its industry group is Biotechnology. It names Alex Wilson (Director), Nicole Robb (Director), Cary Gunn (Executive Officer, Director) (SEC Form D, September 28, 2026).
Sell to companies like Pictura Bio US, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-09-28 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Pictura Bio US, Inc.
Free to see. No signup.
We'll show it in your MentionFox inbox when Pictura Bio US, Inc. raises, hires or launches. No email unless you switch it on.
Watch Pictura Bio US, Inc. →Get the full cited report on Pictura Bio US, Inc.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Pictura Bio US, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Pictura Bio US, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $9.13M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Alex Wilson is named as Director on the Form D that Pictura Bio US, Inc. filed with the SEC on 28 September 2026, one of 4 people that filing names.
Nicole Robb is named as Director on the Form D that Pictura Bio US, Inc. filed with the SEC on 28 September 2026, one of 4 people that filing names.
Cary Gunn is named as Executive Officer and Director on the Form D that Pictura Bio US, Inc. filed with the SEC on 28 September 2026, one of 4 people that filing names.
Steven Powell is named as Director on the Form D that Pictura Bio US, Inc. filed with the SEC on 28 September 2026, one of 4 people that filing names.
4 people named on the filing — 1 holding an executive role and 3 as directors only.
Named as of the 2026-09-28 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Pictura Bio US, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Pictura Bio US, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Pictura Bio US, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Pictura Bio US, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Pictura Bio US, Inc.. With no account yet, you sign up free and land on the result.
https://mentionfox.com/funding/pictura-bio-us-inc-form-d-000002